Can group classes boost cancer prevention in High-Risk women?
NCT ID NCT06549153
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether group education sessions can help medically underserved women and racial/ethnic minorities with BRCA 1 or 2 mutations follow recommended cancer surveillance and risk-reducing procedures. Thirty participants will attend 90-minute group classes via Zoom. The goal is to see if this approach is feasible and acceptable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Education Content
- What this could lead to
- If successful, this could show that group education improves adherence to cancer prevention guidelines for high-risk women.
- What could go wrong
- This is a small feasibility study with only 30 participants, so results may not apply broadly. The intervention is educational, not a direct treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?